TCP
BIIB icon

Tourbillon Capital Partners’s Biogen BIIB Stock Holding History

Tourbillon Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-125,801
Closed -$34.4M – 75
2018
Q1 		$34.4M Buy
+125,801
New +$39M 1.37% 29
2015
Q3 		– Sell
-50,000
Closed -$20.2M – 99
2015
Q2 		$20.2M Buy
+50,000
New +$20.1M 0.44% 64
2014
Q2 		– Sell
-60,000
Closed -$18.4M – 72
2014
Q1 		$18.4M Buy
+60,000
New +$19M 0.86% 30

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Tourbillon Capital Partners's BIIB Position: Q2 2018 in Review

Tourbillon Capital Partners sold out of Biogen (BIIB) in Q2 2018, closing a stake of 125,801 shares — an estimated $34.4M sold.

Tourbillon Capital Partners first reported a position in BIIB in Q1 2014 and held it in 3 quarters. The position peaked at $34.4M in Q1 2018. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Tourbillon Capital Partners reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Tourbillon Capital Partners sold 125,801 Biogen shares in Q2 2018, an estimated $34.4M.
  • Tourbillon Capital Partners first reported a position in Biogen in Q1 2014 and held it in 3 quarters.
  • Tourbillon Capital Partners's Biogen position peaked at $34.4M in Q1 2018.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Tourbillon Capital Partners's 13F filing for Q2 2018, filed 14 Aug 2018.